PLAY PODCASTS
208 - The Opioid Epidemic: What's Next With Purdue Pharma's $8.3 Billion Settlement and How COVID-19 is Intensifying The Public Health Crisis
Season 2 · Episode 208

208 - The Opioid Epidemic: What's Next With Purdue Pharma's $8.3 Billion Settlement and How COVID-19 is Intensifying The Public Health Crisis

Public Health On Call · Johns Hopkins Bloomberg School of Public Health

November 24, 202015m 5s

Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

Last week, a judge approved the $8.3 billion settlement between the Department of Justice and OxyContin manufacturer Purdue Pharma. Hopkins opioids researcher Dr. Caleb Alexander talks with Stephanie Desmon about expected fallout from the settlement as well as how the COVID-19 pandemic is exacerbating the crisis by disrupting drug markets, shuttering treatment centers, and reducing the chances of Naloxone administration in overdose emergencies.

KEYWORDS: substance use; policy